The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Invus Public Equities Advisors, Llc since year 2005.
The trader's CIK number is 1340096.
At the time of this reporting, Invus Public Equities Advisors, Llc is the Director of Lexicon Pharmaceuticals, Inc. .
(stock ticker symbol LXRX).
See this page for all insider trading activities at Lexicon Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-11-17||LXRX||Lexicon Pharmaceuticals, Inc.||Buy||50,000||9.85||492,500|
|2017-11-15||LXRX||Lexicon Pharmaceuticals, Inc.||Buy||130,727||10.21||1,334,461|
|2017-11-14||LXRX||Lexicon Pharmaceuticals, Inc.||Buy||215,133||9.47||2,037,954|
|2017-11-13||LXRX||Lexicon Pharmaceuticals, Inc.||Buy||215,133||9.75||2,097,977|
|2017-11-10||LXRX||Lexicon Pharmaceuticals, Inc.||Buy||145,680||9.74||1,418,340|
|2014-11-26||LXRX||Lexicon Pharmaceuticals, Inc.||Buy||149,253,731||1.00||149,999,999|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Invus Public Equities Advisors, Llc (Director of Lexicon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.